These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23395970)

  • 1. Adsorption of plasma proteins on uncoated PLGA nanoparticles.
    Sempf K; Arrey T; Gelperina S; Schorge T; Meyer B; Karas M; Kreuter J
    Eur J Pharm Biopharm; 2013 Sep; 85(1):53-60. PubMed ID: 23395970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative examination of adsorption of serum proteins on HSA- and PLGA-based nanoparticles using SDS-PAGE and LC-MS.
    Gossmann R; Fahrländer E; Hummel M; Mulac D; Brockmeyer J; Langer K
    Eur J Pharm Biopharm; 2015 Jun; 93():80-7. PubMed ID: 25813886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system.
    Kim HR; Andrieux K; Delomenie C; Chacun H; Appel M; Desmaële D; Taran F; Georgin D; Couvreur P; Taverna M
    Electrophoresis; 2007 Jul; 28(13):2252-61. PubMed ID: 17557357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
    Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P
    Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
    Chen YC; Hsieh WY; Lee WF; Zeng DT
    J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucosylated polymeric nanoparticles: a sweetened approach against blood compatibility paradox.
    Thasneem YM; Sajeesh S; Sharma CP
    Colloids Surf B Biointerfaces; 2013 Aug; 108():337-44. PubMed ID: 23563302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
    Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
    Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functional dissection of the plasma corona of SiO₂-NPs spots histidine rich glycoprotein as a major player able to hamper nanoparticle capture by macrophages.
    Fedeli C; Segat D; Tavano R; Bubacco L; De Franceschi G; de Laureto PP; Lubian E; Selvestrel F; Mancin F; Papini E
    Nanoscale; 2015 Nov; 7(42):17710-28. PubMed ID: 26451907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface modification of PLGA microspheres.
    Müller M; Vörös J; Csúcs G; Walter E; Danuser G; Merkle HP; Spencer ND; Textor M
    J Biomed Mater Res A; 2003 Jul; 66(1):55-61. PubMed ID: 12833431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate.
    Pignatello R; Cenni E; Micieli D; Fotia C; Salerno M; Granchi D; Avnet S; Sarpietro MG; Castelli F; Baldini N
    Nanomedicine (Lond); 2009 Feb; 4(2):161-75. PubMed ID: 19193183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of poly(lactic-co-glycolic acid) nanoparticle surface charge on protein, cellular and haematological interactions.
    Pillai GJ; Greeshma MM; Menon D
    Colloids Surf B Biointerfaces; 2015 Dec; 136():1058-66. PubMed ID: 26590899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate.
    Cenni E; Granchi D; Avnet S; Fotia C; Salerno M; Micieli D; Sarpietro MG; Pignatello R; Castelli F; Baldini N
    Biomaterials; 2008 Apr; 29(10):1400-11. PubMed ID: 18191195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interfacial properties of hydrophilized poly(lactic-co-glycolic acid) layers with various thicknesses.
    Gyulai G; Pénzes CB; Mohai M; Lohner T; Petrik P; Kurunczi S; Kiss É
    J Colloid Interface Sci; 2011 Oct; 362(2):600-6. PubMed ID: 21777919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of PLGA nanoparticles with human blood constituents.
    Kim D; El-Shall H; Dennis D; Morey T
    Colloids Surf B Biointerfaces; 2005 Feb; 40(2):83-91. PubMed ID: 15642458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P; Xu Y; Zeng C; Ren H; Peng M
    Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone.
    Choi SW; Kim JH
    J Control Release; 2007 Sep; 122(1):24-30. PubMed ID: 17628158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charged nanoparticles as protein delivery systems: a feasibility study using lysozyme as model protein.
    Cai C; Bakowsky U; Rytting E; Schaper AK; Kissel T
    Eur J Pharm Biopharm; 2008 May; 69(1):31-42. PubMed ID: 18023160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Ohashi K; Kabasawa T; Ozeki T; Okada H
    J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of protein binding on the biodistribution of PEGylated PLGA nanoparticles post oral administration.
    Semete B; Booysen L; Kalombo L; Ramalapa B; Hayeshi R; Swai HS
    Int J Pharm; 2012 Mar; 424(1-2):115-20. PubMed ID: 22227605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.